Viridian Therapeutics Ors Inc (VRDN)
Operating Cash Flow (Statement)
-$333.34M
TTM · Period ending: · USD
VRDN Operating Cash Flow (Statement)
Latest reported-$333.34Mperiod ending
Latest reported-$333.34Mperiod ending
VRDN TTM Cash from Operations (-$1.17M → -$333.34M)
TTM operating cash flow (statement)
High-resolution chart · PNG
VRDN operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -333,343,000 | |
| -303,392,000 | |
| -276,391,000 | |
| -325,969,000 | |
| -309,064,000 | |
| -279,749,000 | |
| -232,319,000 | |
| -196,987,000 | |
| -168,264,000 | |
| -167,420,000 | |
| -184,170,000 | |
| -180,212,000 | |
| -161,897,000 | |
| -134,769,000 | |
| -93,838,000 | |
| -76,331,000 | |
| -67,539,000 | |
| -64,084,000 | |
| -54,581,000 | |
| -47,482,000 | |
| -40,701,000 | |
| -32,859,000 | |
| -29,779,000 | |
| -28,149,000 | |
| -32,321,000 | |
| -32,706,000 | |
| -36,056,000 | |
| -36,425,000 | |
| -33,960,000 | |
| -31,292,000 | |
| -26,844,000 | |
| -25,912,000 | |
| -24,773,000 | |
| -27,345,000 | |
| -28,167,000 | |
| -22,801,000 | |
| -18,262,000 | |
| -13,192,000 | |
| -7,231,000 | |
| -6,653,000 | |
| -7,833,000 | |
| -8,011,000 | |
| -6,898,000 | |
| -6,595,750 | |
| -5,122,777 | |
| -3,407,188 | |
| -2,213,000 | |
| -1,573,796 | |
| -1,038,945 | |
| -714,910 | |
| -1,167,793 |